Parkinson's Disease Trial, Recruiting NCT07380737 Sponsor: Tel-Aviv Sourasky Medical Center Condition: Parkinson's Disease
Back to Parkinsons Disease

Parkinson's Disease Trial, Recruiting

NCT07380737
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with Parkinson's disease (the type with no known cause, confirmed by standard medical guidelines)
  • Your Parkinson's symptoms are in the middle range of severity — not very mild and not very severe — when you are on your medication
  • You are able to walk on your own for at least 5 minutes without help
  • Your Parkinson's medications have stayed the same for at least 1 month
  • You are currently taking part in a rehabilitation program at Ezra LeMarpe
  • You are able to read, understand, and sign a consent form agreeing to take part

Who may not be able to join:

  • You have a bone, joint, nerve, vision, or hearing problem that affects the way you walk
  • You have memory, thinking, or serious behavioral difficulties
  • You have a history of stroke, a serious brain injury, or a brain tumor
  • You have a heart or blood vessel condition that makes physical activity or certain treatments unsafe (confirm with trial site)
  • You are not able to use a smartphone
  • You are currently taking part in another research study that involves a treatment or intervention

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 5 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Tatyana Gurevich, Prof, Head of the Movement Disorders Unit at Ichilov Hospital

Phone: +972-3-6947514

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
29 December 2025
Est. completion
31 August 2026

Where this trial is recruiting

🇮🇱 Israel

Primary endpoints

Average Step Count Per Day; Daily Walking Duration (minutes/week)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 5 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov